Skip to content

Author

L. Van Kaer

We have 4 of 438 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Natural killer T cells as therapeutic targets for neuroinflammatory disorders

ABSTRACT Natural killer T (NKT) cells are innate-like T lymphocytes that express natural killer (NK) cell receptors (NKRs), which recognize glycolipid antigens presented by the MHC class I-like protein CD1d, linking innate and adaptive immunity. NKT cells include two main subsets, type I and type II, which differ in TC...

Hyunkyung Park, Sung Won Lee, Tae-Cheol Kim et al. · 0 citations
Open access Oct 2026

Why a positive rheumatoid factor test does not always mean rheumatoid arthritis

Rheumatoid factors (RFs) are autoantibodies directed against the tail region of IgG antibodies and are present in a majority of people with rheumatoid arthritis (RA). RF production is commonly assessed to help diagnose RA, but its performance is limited due to low specificity and sensitivity for reasons that have remai...

L. Van Kaer · 0 citations
Aug 2026

Maternal NKG2D-mediated immune activation shapes fetal neural development.

It is demonstrated that MIA significantly increases the proportion of NK cells at the maternal-fetal interface, characterized by elevated expression of NKG2D, with this local accumulation persisting until late gestation, highlighting NK cell modulation as a potential therapeutic strategy for maternal infection-associat...

Rongrong Liu, Yuexin Zhao, Xianli Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.